Clinical Trial Update: Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the pharmacologic interaction between ifosfamide and aprepitant in treated patients with soft tissue sarcoma; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Aprepitant (aprepitant)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Soft Tissue Sarcoma | Phase 4 | Status: COMPLETED